Therapy of Non-Hodgkin-Lymphoma by Combination of Lenalidomide + Rituximab, Dexa, High-dose ARA-C and CisP

Clinical trial NCT02983097 · TERMINATED

Trial details

NCT number: NCT02983097
Sponsor: Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Diffuse Large B-cell Lymphoma (DLBCL)Follicular Lymphoma Grade III (FL III°)Mantle Cell Lymphoma (MCL), Blastoid Variant Burkitt Lymphoma (BL)Aggressive Marginal Zone Lymphoma (MZL)

Start date: 2010-11-01
Primary completion: 2014-01-01
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.